Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease

Genes Chromosomes and Cancer

Volumn 48, Issue 2, 2009, Pages 171-178

  Klemke, Markus ^a   Meyer, Anke ^a   Nezhad, Maliheh Hashemi ^a   Bartnitzke, Sabine ^a   Drieschner, Norbert ^a   Frantzen, Christiane ^b   Schmidt, Ernst Heinrich ^c   Belge, Gazanfer ^a   Bullerdiek, Jörn ^a,d  

^a UNIVERSITY OF BREMEN   (Germany)

^b Augenklinik St Joseph Stift   (Germany)

^c Diako Hospital   (Germany)

^d UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; MYOMETRIUM; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; UTERUS MYOMA;

CHROMOSOME ABERRATIONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HMGA2 PROTEIN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEIOMYOMA; MYOMETRIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UTERINE NEOPLASMS; UTERUS;

EID: 59949105923     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20627     Document Type: Article

References (39)

1. Ashar HR, Fejzo MS, Tkachenko A, Zhou X, Fletcher JA, Were- mowicz S, Morton CC, Chada K. 1995. Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82:57-65.
2. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. 2003. High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. Am J Obstet Gynecol 188:100-107.
3. Belge G, Meyer A, Klemke M, Burchardt K, Stern C, Wosniok W, Loeschke S, Bullerdiek J. 2008. Upregulation of HMGA2 in thyroid carcinomas: A novel molecular marker to distinguish between benign and malignant follicular neoplasias. Genes Chromosomes Cancer 47:56-63.
4. Bullerdiek J. 1997. The molecular target of 12q14-15 aberrations in benign solid tumors. HMGIC rearrangements and beyond. Fourth International workshop on chromosome 12 mapping. Kucherlapati R, Marynen P, Turc-Carel C, editors. Book of abstracts. Nice: Organizing Comittee of the Meetings.
5. Cramer SF, Patel A. 1990. The frequency of uterine leiomyomas. Am J Clin Pathol 94:435-438.
6. Fusco A, Fedele M. 2007. Roles of HMGA proteins in cancer. Nat Rev Cancer 7:899-910.
7. Gross KL, Neskey DM, Manchanda N, Weremowicz S, Kleinman MS, Nowak RA, Ligon AH, Rogalla P, Drechsler K, Bullerdiek J, Morton CC. 2003. HMGA2 expression in uterine leiomyomata and myometrium: Quantitative analysis and tissue culture studies. Genes Chromosomes Cancer 38:68-79.
8. Hashimoto K, Azuma C, Kamiura S, Kimura T, Nobunaga T, Kanai T, Sawada M, Noguchi S, Saji F. 1995. Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene. Gynecol Obstet Invest 40:204-208.
9. Heinemann K, Thiel C, Möhner S, Lewis MA, Raff T, Kühl-Habich D, Heinemann LA. 2003. Benign gynecological tumors: Estimated incidence. Results of the German Cohort Study on Women's Health. Eur J Obstet Gynecol Reprod Biol 107:78-80.
10. Hennig Y, Wanschura S, Deichert U, Bartnitzke S, Bullerdiek J. 1996. Rearrangements of the high mobility group protein family genes and the molecular genetic origin of uterine leiomyomas and endometrial polyps. Mol Hum Reprod 2:277-283.
11. Hennig Y, Deichert U, Bonk U, Thode B, Bartnitzke S, Bullerdiek J. 1999. Chromosomal translocations affecting 12q14-15 but not deletions of the long arm of chromosome 7 associated with a growth advantage of uterine smooth muscle cells. Mol Hum Reprod 5:1150-1154.
12. ISCN. 2005. An International System for Human Cytogenetic Nomenclature. In: Shaffer LG, Tommerup N, editors. Basel, Switzerland: S. Karger AG.
13. Kayisli UA, Berkkanoglu M, Kizilay G, Senturk L, Arici A. 2007. Expression of proliferative and preapoptotic molecules in human myometrium and leiomyoma throughout the menstrual cycle. Reprod Sci 14:678-686.
14. Kazmierczak B, Bol S, Wanschura S, Bartnitzke S, Bullerdiek J. 1996. PAC clone containing the HMGI(Y) gene spans the breakpoint of a 6p21 translocation in a uterine leiomyoma cell line. Genes Chromosomes Cancer 17:191-193.
15. Kazmierczak B, Hennig Y, Wanschura S, Rogalla P, Bartnitzke S, van de Ven W, Bullerdiek J. 1995. Description of a novel fusion transcript between HMGI-C, a gene encoding for a member of the high mobility group proteins, and the mitochondrial aldehyde dehydrogenase gene. Cancer Res 55:6038-6039.
16. Kievits T, Dauwerse JG, Wiegant J, Devilee P, Breuning MH, Cornelisse CJ, van Ommen GJ, Pearson PL. 1990. Rapid sub-chromosomal localization of cosmids by nonradioactive in situ hybridization. Cytogenet Cell Genet 53:134-136.
17. Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA, Jacks T. 2008. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA 105:3903-3908.
18. Kurose K, Mine N, Doi D, Ota Y, Yoneyama K, Konishi H, Araki T, Emi M. 2000. Novel gene fusion of COX6C at 8q22-23 to HMGIC at 12q15 in a uterine leiomyoma. Genes Chromosomes Cancer 27:303-307.
19. Lee YS, Dutta A. 2007. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21:1025-1030.
20. Li O, Li J, Dröge P. 2007. DNA architectural factor and protooncogene HMGA2 regulates key developmental genes in pluripotent human embryonic stem cells. FEBS Lett 581:3533-3537.
21. Li O, Vasudevan D, Davey CA, Dröge P. 2006. High-level expression of DNA architectural factor HMGA2 and its association with nucleosomes in human embryonic stem cells. Genesis 44:523-529.
22. Mashal RD, Fejzo ML, Friedman AJ, Mitchner N, Nowak RA, Rein MS, Morton CC, Sklar J. 1994. Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata. Genes Chromosomes Cancer 11:1-6.
23. Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA, Willett WC, Hunter DJ. 1998. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 90:967-973.
24. Mayr C, Hemann MT, Bartel DP. 2007. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315:1576-1579.
25. Mine N, Kurose K, Konishi H, Araki T, Nagai H, Emi M. 2001. Fusion of a sequence from HEI10 (14q11) to the HMGIC gene at 12q15 in a uterine leiomyoma. Jpn J Cancer Res 92:135-139.
26. Motoyama K, Inoue H, Nakamura Y, Uetake H, Sugihara K, Mori M. 2008. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clin Cancer Res 14:2334-2340.
27. Nilbert M, Heim S. 1990. Uterine leiomyoma cytogenetics. Genes Chromosomes Cancer 2:3-13.
28. Park SM, Shell S, Radjabi AR, Schickel R, Feig C, Boyerinas B, Dinulescu DM, Lengyel E, Peter ME. 2007. Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 6:2585-2590.
29. Peng Y, Laser J, Shi G, Mittal K, Melamed J, Lee P, Wei JJ. 2008. Antiproliferative effects by let-7 repression of high-mobility group A2 in uterine leiomyoma. Mol Cancer Res 6:663-673.
30. Quade BJ, Weremowicz S, Neskey DM, Vanni R, Ladd C, Dal Cin P, Morton CC. 2003. Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15. Cancer Res 63:1351-1358.
31. Schoenmakers EF, Huysmans C, van de Ven WJ. 1999. Allelic knockout of novel splice variants of human recombination repair gene RAD51B in t(12;14) uterine leiomyomas. Cancer Res 59:19-23.
32. Schoenmakers EF, Wanschura S, Mols R, Bullerdiek J, van den Berghe H, van de Ven WJ. 1995. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet 10:436-444.
33. Shell S, Park SM, Radjabi AR, Schickel R, Kistner EO, Jewell DA, Feig C, Lengyel E, Peter ME. 2007. Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci USA 104:11400-11405.
34. Stewart EA. 2001. Uterine fibroids. Lancet 357:293-298.
35. Takahashi T, Nagai N, Oda H, Ohama K, Kamada N, Miyagawa K. 2001. Evidence for RAD51L1/HMGIC fusion in the pathogenesis of uterine leiomyoma. Genes Chromosomes Cancer 30:196-201.
36. Tallini G, Vanni R, Manfioletti G, Kazmierczak B, Faa G, Pauwels P, Bullerdiek J, Giancotti V, van Den Berghe H, Dal Cin P. 2000. HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes. Lab Invest 80:359-369.
37. Townsend DE, Sparkes RS, Baluda MC, McClelland G. 1970. Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate dehydrogenase. Am J Obstet Gynecol 107:1168-1173.
38. Weremowicz S, Morton CC. 1999. Is HMGIC rearranged due to paracentric inversion of 12q in karyotypically normal uterine leiomyomas? Genes Chromosomes Cancer 24: 172-173.
39. Zhang P, Zhang C, Hao J, Sung CJ, Quddus MR, Steinhoff MM, Lawrence WD. 2006. Use of X-chromosome inactivation pattern to determine the clonal origins of uterine leiomyoma and leiomyosarcoma. Hum Pathol 37:1350-1356.